Medscape Asks Whether Statins Still Matter in GLP-1 Era
Commentary weighs the continued role of lipid-lowering statin therapy as GLP-1 receptor agonists reshape cardiometabolic care.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 15:56 ETSource: Medscape
The wire
- 01Medscape published a piece examining statin relevance alongside widespread GLP-1 use.
- 02Cardiometabolic prescribing patterns may shift as GLP-1 drugs show broad metabolic effects.
- 03No new trial data cited; clinical guidance on combined use remains unsettled.
From the source
Read at news.google.comDo Statins Still Matter in the GLP-1 Era?